GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Inventory-to-Revenue

LTR Pharma (ASX:LTP) Inventory-to-Revenue : 0.00 (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. LTR Pharma's Average Total Inventories for the quarter that ended in Jun. 2023 was A$0.00 Mil. LTR Pharma's Revenue for the six months ended in Jun. 2023 was A$0.00 Mil.

LTR Pharma's Inventory-to-Revenue for the quarter that ended in Jun. 2023 stayed the same from Jun. 2022 (0.00) to Jun. 2022 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.


LTR Pharma Inventory-to-Revenue Historical Data

The historical data trend for LTR Pharma's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Inventory-to-Revenue Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23
Inventory-to-Revenue
- - -

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23
Inventory-to-Revenue - - -

Competitive Comparison of LTR Pharma's Inventory-to-Revenue

For the Biotechnology subindustry, LTR Pharma's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LTR Pharma's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where LTR Pharma's Inventory-to-Revenue falls into.



LTR Pharma Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

LTR Pharma's Inventory-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Inventory-to-Revenue (A: Jun. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Jun. 2022 ) + Total Inventories (A: Jun. 2023 )) / count ) / Revenue (A: Jun. 2023 )
=( (0 + 0) / 1 ) / 0
=0 / 0
=N/A

LTR Pharma's Inventory-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue (Q: Jun. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jun. 2022 ) + Total Inventories (Q: Jun. 2023 )) / count ) / Revenue (Q: Jun. 2023 )
=( (0 + 0) / 1 ) / 0
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LTR Pharma  (ASX:LTP) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

LTR Pharma's Days Inventory for the six months ended in Jun. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Jun. 2023 )/Cost of Goods Sold (Q: Jun. 2023 )*Days in Period
=0/0*365 / 2
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

LTR Pharma's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2023 ) / Average Total Inventories (Q: Jun. 2023 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LTR Pharma Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


LTR Pharma (ASX:LTP) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines